2421. Tedizolid Is Well-Tolerated Among Patients Receiving Prolonged Treatment Courses
Sign Up to like & getrecommendations! Published in 2018 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofy210.2074
Abstract: Abstract Background Tedizolid (TED) is a newly-approved oxazolidinone antibiotic that may be better tolerated than linezolid; however, real-world clinical data are limited, particularly among patients receiving prolonged treatment courses. Our objective was to review our… read more here.
Keywords: among patients; treatment; patients receiving; well tolerated ... See more keywords